Related Experiment Video
Updated: Jun 18, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Venous thromboembolism in malignant gliomas
E O Jenkins1, D Schiff, N Mackman
1Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Journal of Thrombosis and Haemostasis : JTH
|November 17, 2009
Summary
Malignant gliomas patients face high venous thromboembolism (VTE) risk. Understanding risks from therapies like bevacizumab and identifying biomarkers are crucial for preventing VTE and improving outcomes.
Area of Science:
- Neuro-oncology
- Hematology
- Oncology
Background:
- Malignant gliomas carry a significant risk of venous thromboembolism (VTE).
- Existing clinical risk factors for VTE in brain tumor patients are known, but the impact of novel anti-angiogenic therapies like bevacizumab remains unclear.
- VTE in this population complicates anticoagulation due to intracranial hemorrhage concerns and is linked to poorer prognosis.
Purpose of the Study:
- To clarify the risk of VTE associated with bevacizumab in malignant glioma patients.
- To explore potential predictive plasma biomarkers for VTE risk stratification.
- To investigate the role of disordered coagulation and molecular signaling in glioma-associated VTE.
Main Methods:
- Review of clinical risk factors in brain tumor patients.
- Analysis of VTE incidence in patients treated with bevacizumab.
- Exploration of coagulation pathways and molecular signaling in malignant gliomas.
Main Results:
- The risk of VTE in malignant glioma patients is substantial.
- Bevacizumab's specific contribution to VTE risk requires further investigation.
- Disordered coagulation, including tissue factor expression, is implicated in glioma-VTE.
Conclusions:
- Accurate risk stratification and predictive biomarkers are needed for primary VTE prevention in high-risk glioma patients.
- Understanding the prothrombotic mechanisms in malignant gliomas is essential for effective management.
- Further research is warranted to guide thromboprophylaxis strategies in this vulnerable patient group.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...